It is used off-label only under specialist advice, as potential risks include increased risk of haemorrhagic stroke and other adverse effects
Ingredientes completos: Agua, L-Carnitina base 1,053 g, Aroma (Aroma fresa), L-Carnitina tartrato 526,32 mg, Colina bitartrato 451,86 mg (185,26 mg de Colina), Correctores de acidez (cido ctrico y cido mlico), Conservador (Sorbato potsico), Edulcorante (Sucralosa), Vitamina B6 (Clorhidrato de piridoxina) 2,11 mg (150,71% VRN*), Tiamina (Clorhidrato de tiamina) 1,47 mg (133,63% VRN*)
Heat production is carried out in the presence of uncoupling protein-1 (UCP-1)
These compounds can potentiate the activity of existing antibiotics by enhancing their efficacy against a broad spectrum of pathogens
FOXO4-DRI is among the highest-risk research peptides from an evidence-to-risk standpoint: it has never been tested in humans, no human pharmacokinetic data exists, and as a senolytic it carries theoretical risks specific to its mechanism
Researchers are intrigued